SPHERIX INC (30)

Browse by Contract Category

Contracts

Amendment No. 3 to the Employment Agreement with Anthony Hayes, dated June 28, 2021 (Filed With SEC on July 2, 2021)
Amendment to Exclusive Patent License Agreement, dated April 12, 2021 (Filed With SEC on April 16, 2021)
Form of Underwriters Warrant (Filed With SEC on February 18, 2021)
Engagement Agreement, dated January 24, 2020, as amended on March 2, 2020, between AIkido Pharma Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 26, 2020)
Exclusive Patent License Agreement by and among Silo Pharma Inc., a Delaware corporation and Silo Pharma Inc., a Florida corporation, and their affiliates/subsidiaries... (Filed With SEC on April 16, 2021)
Amended and Restated Underwriting Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated February 16, 2021 (Filed With SEC on February 18, 2021)
Convertible Promissory Note dated January 29, 2021 (Filed With SEC on February 3, 2021)
Securities Purchase Agreement by and between Convergent Therapeutics, Inc. and the Company, dated January 29, 2021 (Filed With SEC on February 3, 2021)
Form of Securities Purchase Agreement (Filed With SEC on April 15, 2020)
Form of Placement Agents Warrant (Filed With SEC on April 15, 2020)
Rights Agreement, dated as of March 23, 2020, by and between AIkido Pharma Inc., as the Company, and VStock Transfer, LLC, as Rights Agent (Filed With SEC on March 25, 2020)
Form of Placement Agents Warrant (Filed With SEC on March 10, 2020)
Form of Securities Purchase Agreement (Filed With SEC on March 10, 2020)
Form of Common Warrant (Filed With SEC on February 28, 2020)
Form of Securities Purchase Agreement (Filed With SEC on February 28, 2020)
Form of Placement Agent Warrant (Filed With SEC on February 28, 2020)
Form of Pre-Funded Warrant (Filed With SEC on February 28, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among Wake Forest University Health Sciences, CBM BioPharma, Inc. and Spherix Incorporated (Filed With SEC on February 3, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among The University of Texas in Austin, on behalf of the Board of Regents of the University of Texas, CBM... (Filed With SEC on February 3, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among The University of Texas in Austin, on behalf of the Board of Regents of the University of Texas, CBM... (Filed With SEC on January 31, 2020)
Assignment of Agreement, dated as of November 13, 2019, by and among Wake Forrest University Health Sciences, CBM BioPharma, Inc. and Spherix Incorporated (Filed With SEC on January 31, 2020)
Amendment No. 2 to Asset Purchase Agreement, dated as of December 5, 2019, by and between the Company and CBM BioPharma, Inc (Filed With SEC on December 10, 2019)
At The Market Offering Agreement, dated August 9, 2019, by and between Spherix Incorporated and H.C. Wainwright & Co., LLC (Filed With SEC on August 12, 2019)
Form of Amendment to Securities Purchase Agreement, dated June 6, 2019, by and between the Company and the purchaser party thereto (Filed With SEC on June 7, 2019)
Form of Warrant (Filed With SEC on June 7, 2019)
Amendment No. 1 to Asset Purchase Agreement, dated May 30, 2019, by and between the Company and CBM BioPharma, Inc (Filed With SEC on May 31, 2019)
Form of Securities Purchase Agreement, dated May 29, 2019, by and between the Company and the purchaser party thereto (Filed With SEC on May 31, 2019)
Form of Warrant (Filed With SEC on May 31, 2019)
Form of Share Purchase Agreement, dated May 15, 2019, by and between Spherix Incorporated and the sellers signatory thereto (Filed With SEC on May 15, 2019)
Asset Purchase Agreement, dated May 15, 2019, by and between Spherix Incorporated and CBM Biopharma, Inc (Filed With SEC on May 15, 2019)